canvas and control postmortem brain tissue (Partners HealthCare System Inc)
Structured Review

Canvas And Control Postmortem Brain Tissue, supplied by Partners HealthCare System Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/canvas+and+control+postmortem+brain+tissue/harvard+brain+tissue+resource+center/pmc11373605-284-2-33
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons"
Article Title: AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons
Journal: Science Advances
doi: 10.1126/sciadv.adn2321
Figure Legend Snippet: ( A ) Schematic of brain, central and peripheral nervous system regions affected in CANVAS (left), and potential mechanisms of repeat toxicity in CANVAS (right). ( B ) Repeat architecture of the expanded locus and CRISPR gRNA design to remove the AAGGG/CCCTT repeat expansion by nonhomologous end joining (NHEJ). ( C ) Endpoint PCR of gDNA extracted from CANVAS patient– and control-derived iPSC lines and CANVAS and control cerebellum tissue utilizing the primer pair outlined in (B) to screen for the presence of WT repeat, mutant repeat expansion, or deletion of expanded repeat. ( D ) Chromatogram of Sanger sequencing identifying AAGGG/CCCTT allele deletion in heterozygous isogenic line indicating the expected NHEJ join point compared to the control iPSC line. ( E ) Schematic outlining the repeat copy number per allele for each of the patient-derived iPSC lines used as identified by Oxford Nanopore gDNA targeted long-read sequencing. Green, sub-pathogenic repeat length; Red, pathogenic repeat length. Error bars indicate confidence in exact copy number calls. The “*” indicates lower boundary for repeat copy number from the longest read observed due to the absence of reads spanning the full repeat.
Techniques Used: CRISPR, Control, Derivative Assay, Mutagenesis, Sequencing
Figure Legend Snippet: ( A ) Schematic of potential peptide products from sense and antisense strand of the repeat expansion locus. ( B ) Quantification of foci positive neurons for control ( n = 3) and CANVAS ( n = 3) patient iPSC-derived neurons (1100 to 2000 cells per group per probe). n = 2 biological replicates from three independent patient-derived cell lines. Representative confocal images are shown in fig. S2B. ( C ) Immunoblot from HEK293 cells expressing plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters in the +0/+1/+2 reading frames (left) and Nano-luciferase expression assay quantification (right). n = 7 biological replicates. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D ) ICC of HEK293 cells transfected with plasmids encoding intronic sense or antisense AAGGG/CCCTT repeat reporters with C-terminal triple tags in the +0/+1/+2 reading frames. ( E ) Expression analysis of lysates from HEK293 cells transfected with control plasmid +2 Sense (AAGGG) 61 plasmid using anti-FLAG M2 (1:1000) and anti-KGREG (1:100) antibodies (left). ( F ) Left: IHC of control and RFC1 expansion CANVAS patient postmortem cerebellar vermis tissue stained with sense anti-KGREG antibody (1:100, acid AR). Scale bars, 500 μm (4×), 50 μm (60×), and 20 μm (inset). Right: Rater blinded quantification of all 20 postmortem tissues (tissue images and quantification for each sample in fig. S4). ( G ) Cumulative hazard plot for rat cortical neurons expressing CGG100 (positive control) or CANVAS intronic expression plasmids containing 61 repeats of the indicated type over 10 days. Results from eight technical replicates/three biological replicates; n = numbers of cells assessed per condition. ns, not significant. *hazard ratio = 1.339, P = 0.025, Cox proportional hazards analysis.
Techniques Used: Control, Derivative Assay, Western Blot, Expressing, Luciferase, Comparison, Transfection, Plasmid Preparation, Staining, Positive Control
Figure Legend Snippet: ( A ) Endpoint RT-PCR utilizing primer sets spanning RFC1 exon 2–exon 3 or exon 2–intron 2 in CANVAS fibroblasts (top, left), iPSC-derived neurons (top, right), and CANVAS postmortem brain (bottom, left). ( B ) Quantification of normalized circular back-spliced read counts for RFC1 and other known circRNA species in CANVAS patient iPSC–derived neurons by paired-end RNA-seq analysis. ( C ) Ten-day time-course analysis of the rate of cellular division and proliferation in CANVAS ( n = 4) and control ( n = 3) fibroblast lines (left, F 6,287 = 8.54, P < 0.0001), CANVAS ( n = 3) and control ( n = 3) NPC lines (center, F 5,240 = 12.88, P < 0.0001), and CANVAS fibroblast lines ( n = 3) mock-treated or treated with RFC1 overexpression lentivirus (right, F 5,240 = 2.358, P = 0.245). n = 3 biological replicates from three to four independent patient cell lines. Data were analyzed by one-way ANOVA with Sidak’s post hoc multiple comparison tests. ( D and E ) Analysis of recovery after discrete UV exposure and DNA damage in CANVAS patient iPSC–derived neurons. (D) Representative images of γ-H2AX staining of iPSC-derived neurons before and after 60 mJ/cm 2 UV exposure (scale bar, 10 μm). (E) Quantification of mean γ-H2AX staining in CANVAS patient ( n = 3) and control ( n = 3) iPSC–derived NeuN+ neuronal nuclei over a 24-hour period after 60 mJ/cm 2 UV exposure ( n = 16,569 NeuN+ nuclei total). Data were analyzed by one-way ANOVA with post hoc multiple comparison tests. ( F ) First-derivative DNA damage recovery rate curves for CANVAS ( n = 3) and control ( n = 3) patient iPSC–derived neurons. Error = SD.
Techniques Used: Reverse Transcription Polymerase Chain Reaction, Derivative Assay, RNA Sequencing, Control, Over Expression, Comparison, Staining
Related Articles
Control:Article Title: AAGGG repeat expansions trigger RFC1 -independent synaptic dysregulation in human CANVAS neurons Article Snippet: .. CANVAS and |